Warby Parker (WRBY) Morgan Stanley Global Consumer & Retail Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley Global Consumer & Retail Conference summary
12 Jan, 2026Strategic initiatives and business evolution
Continued investment in omnichannel offerings, opening 40 stores annually, and planning for several hundred more in coming years.
Focused on increasing brand awareness and scaled media mix, resulting in six consecutive quarters of accelerating active customer growth.
Expanded into holistic eye care, scaling contact lens and eye exam offerings, and introduced higher-end products like precision progressives.
Maintained strong digital experience and unique omnichannel model, leveraging AI for product recommendations.
Significant growth in both eye exam and contact lens business, aiming to be a one-stop shop for vision care.
Financial performance and outlook
Achieved accelerating top-line revenue growth: 10% two years ago, 12% last year, and guiding to 15% this year.
Gross margins remain in the mid-50s, with glasses as the highest-margin product and progressives being most profitable.
Adjusted EBITDA margin expanded by 330 basis points last year and guided for 170 basis points this year.
Non-marketing SG&A as a percent of revenue improved by 330 basis points, reflecting operational efficiencies.
Continued focus on leveraging corporate overhead and careful capital allocation for customer acquisition and store rollouts.
Industry trends and market dynamics
Optical industry experienced volatility post-pandemic, with elongated repurchase cycles and lower demand in 2022–2023.
Expecting normalization and potential pent-up demand to drive growth in coming years.
Unique omnichannel and digital capabilities position the company to capture share as demand returns.
Industry split between large retail chains and independent practices, with limited e-commerce innovation among competitors.
Anticipates more stability and increased demand as consumers return for exams and new prescriptions.
Latest events from Warby Parker
- 13% revenue growth, first net income, and strong 2026 outlook with AI glasses and expansion.WRBY
Q4 202526 Feb 2026 - Q2 revenue up 13.3% to $188.2M, margins improved, and FY 2024 guidance raised.WRBY
Q2 20242 Feb 2026 - Retail expansion, margin gains, and tech innovation fuel growth amid a stable consumer base.WRBY
TD Cowen’s 8th Annual Future of the Consumer Conference31 Jan 2026 - Diversified marketing, insurance expansion, and tech-driven retail growth fuel strong performance.WRBY
Goldman Sachs 31st Annual Global Retailing Conference22 Jan 2026 - Q3 revenue up 13.3%, margin and net loss improved, and full-year outlook raised.WRBY
Q3 202416 Jan 2026 - Confident growth outlook, margin expansion, and tech innovation drive future performance.WRBY
Goldman Sachs 32nd Annual Global Retailing Conference 202531 Dec 2025 - 2024 revenue up 15.2% to $771.3M, margin expansion, and 45 new stores planned for 2025.WRBY
Q4 202417 Dec 2025 - AI glasses and omnichannel expansion set the stage for transformational growth in 2026.WRBY
Morgan Stanley Global Consumer & Retail Conference 20253 Dec 2025 - Shareholders will vote on directors, auditor, and executive pay, with strong 2024 results reported.WRBY
Proxy Filing1 Dec 2025